Ultradeformable archaeosomes as new topical adjuvants

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 8, Issue 8, 2012, Pages 1319-1328

  Higa, Leticia H ^a   Schilrreff, Priscila ^a   Perez, Ana Paula ^a   Iriarte, Maiara A ^a   Roncaglia, Diana I ^a   Morilla, Maria Jose ^a   Romero, Eder L ^a  

^a UNIVERSIDAD NACIONAL DE QUILMES   (Argentina)

Author keywords

Skin; Topical adjuvants; Vesicles

Indexed keywords

BALB/C MICE; GLYCO LIPIDS; HUMAN SKIN; KERATINOCYTES; MEAN SIZE; OVALBUMINS; POLAR LIPIDS; SKIN DEPTH; SKIN PENETRATION; SODIUM CHOLATE; SOYBEAN PHOSPHATIDYLCHOLINE; TOPICAL ADJUVANTS; TRANSDERMAL DELIVERY; VESICLES;

IMMUNIZATION; LIPOSOMES; SKIN; SODIUM; ZETA POTENTIAL;

PHOSPHOLIPIDS;

CHOLIC ACID; IMMUNOGLOBULIN G; LIPID; LIPOSOME; OVALBUMIN; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; ULTRADEFORMABLE ARCHAEOSOME; ULTRADEFORMABLE LIPOSOME; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CYTOTOXICITY; HUMAN; HUMAN CELL; KERATINOCYTE; MACROPHAGE; MALE; MOUSE; NONHUMAN;

ADMINISTRATION, TOPICAL; ANIMALS; CELL LINE; CELL SURVIVAL; DRUG DELIVERY SYSTEMS; FEMALE; HALORUBRUM; HUMANS; KERATINOCYTES; LIPIDS; LIPOSOMES; MICE; PHOSPHATIDYLCHOLINES; SKIN ABSORPTION; SODIUM CHOLATE; VACCINATION;

GLYCINE MAX; HALORUBRUM TEBENQUICHENSE; MUS;

EID: 84867894149     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2012.02.008     Document Type: Article

References (48)

1. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392:245-252.
2. Nicolas J.F., Guy B. Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice. Expert Rev Vaccines 2008, 7:1201-1214.
3. Combadiere B., Mahe B. Particle-based vaccines for transcutaneous vaccination comparative immunology. Microb Infect Dis 2008, 31:293-315.
4. Partidos C.D., Beignon A.-S., Mawas F., Belliard G., Briand J.-P., Muller S. Immunity under the skin: potential application for topical delivery of vaccines. Vaccine 2003, 21:776-780.
5. Clements C.J., Larsen G., Jodar L. Technologies that make administration of vaccines safer. Vaccine 2004, 22:2054-2058.
6. Giudice E.L., Campbell J.D. Needle-free vaccine delivery. Adv Drug Del Rev 2006, 58:68-89.
7. Warger T., Schild H., Rechtsteiner G. Initiation of adaptive immune responses by transcutaneous immunization. Immunol Lett 2007, 109:13-20.
8. Inoue J., Aramaki Y. Toll-like receptor-9 expression induced by tape-stripping triggers on effective immune response with CpG-oligodeoxynucleotides. Vaccine 2007, 25:1007-1013.
9. Arora A., Prausnitz M.R., Mitragotri S. Micro-scale devices for transdermal drug delivery. Int J Pharm 2008, 364:227-236.
10. Gudmundsdotter L., Wahren B., Haller B.K., Boberg A., Edbäck U., Bernasconi D., et al. Amplified antigen-specific immune responses in HIV-1 infected individuals in a double blind DNA immunization and therapy interruption trial. Vaccine 2011, 29(33):5558-5566.
11. Foldvari M., Badea I., Kumar P., Wettig S., Batta R., King M.J., et al. Biphasic vesicles for topical delivery of interferon alpha in human volunteers and treatment of patients with human papillomavirus infections. Curr Drug Deliv 2011, 8:307-319.
12. Sprott GD, Patel GB, Makabi-Panzu BH, Tolson DL. Archaeosomes, archaeosomes containing coenzyme Q10, and other types of liposomes containing coenzyme Q10 as adjuvants and as delivery vehicles. European Patent 0 869 773 B1 WO 1997/022333 1997.
13. Krishnan L., Sad S., Patel G.B., Sprott G.D. The potent adjuvant activity of archaeosomes correlates to the recruitment and activation of macrophages and dendritic cells in vivo. J Immunol 2001, 166:1885-1893.
14. Nordly P., Korsholm K.S., Pedersen E.A., Khilji T.S., Franzyk H., Jorgensen L., et al. Incorporation of a synthetic mycobacterial monomycoloyl glycerol analogue stabilizes dimethyldioctadecylammonium liposomes and potentiates their adjuvant effect in vivo. Eur J Pharm Biopharm 2011, 77:89-98.
15. Dudani R., Chapdelaine Y., van Faassen H., Smith D.K., Shen H., Krishnan L., et al. Preexisting inflammation due to Mycobacterium bovis BCG infection differentially modulates T-cell priming against a replicating or nonreplicating immunogen. Infect Immun 2002, 70:1957-1964.
16. Stan A.C., Casares S., Brumeanu T.D., Klinman D.M., Bona C.A. CpG motifs of DNA vaccines induce the expression of chemokines and MHC Class II molecules on myocytes. Eur J Immunol 2001, 31:301-310.
17. Lambert P.H., Laurent P.E. Intradermal vaccine delivery: will new delivery systems transform vaccine administration?. Vaccine 2008, 26:3197-3208.
18. Patel G.B., Zhou H., Ponce A., Chen W. Mucosal and systemic immune responses by intranasal immunization using archaeal lipid-adjuvanted vaccines. Vaccine 2007, 25:8622-8636.
19. Gonzalez R.O., Higa L.H., Cutrullis R.A., Bilen M., Morelli I., Roncaglia D.I., et al. Archaeosomes made of Halorubrum tebenquichense total polar lipids: a new source of adjuvancy. BMC Biotechnol 2009, 9:71-83.
20. Kates M.K.S. Protocol 5: Isoprenoids and polar lipids of extreme halophiles. Archaea. A laboratory manual. Halophiles 1995, 35-53. Cold Spring Harbor Laboratory Press, New York. E.M. DSaF (Ed.).
21. Bötcher C.J.F., van Gent C.M., Pries C. A rapid and sensitive submicro phosphorus determination. Anal Chim Acta 1961, 24:203-204.
22. Fry D.W., White J.C., Goldman I.D. Rapid separation of low molecular weight solutes from liposomes without dilution. Anal Biochem 1978, 90:809-815.
23. Lovdahl M.J., Pietrzyk D.J. Anion-exchange separation and determination of bisphosphonates and related analytes by post-column indirect fluorescence detection. J Chromatogr A 1999, 850:143-152.
24. Blight E.G., Dyer W.J. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959, 37:911-917.
25. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
26. van den Bergh B.A., Wertz P.W., Junginger H.E., Bouwstra J.A. Elasticity of vesicles assessed by electron spin resonance, electron microscopy and extrusion measurements. Int J Pharm 2001, 217:13-24.
27. Cevc G. Material transport across permeability barriers by means of lipid vesicles. Handbook of Biological Physics 1995, 465-490. Elsevier, Amsterdam. R.S.E. Lipowsky (Ed.).
28. Montanari J., Maidana C., Esteva M.I., Salomon C., Morilla M.J., Romero E.L. Sunlight triggered photodynamic ultradeformable liposomes against Leishmania braziliensis are also leishmanicidal in the dark. J Control Release 2010, 147:368-376.
29. Moreau M.F., Guillet C., Massin P., Chevalier S., Gascan H., Baslé M.F., et al. Comparative effects of five bisphosphonates on apoptosis of macrophage cells in vitro. Biochem Pharmacol 2007, 73:718-723.
30. Stratis A., Pasparakis M., Rupec R.A., Markur D., Hartmann K., Scharffetter-Kochanek K., et al. Pathogenic role for skin macrophages in a mouse model of keratinocyte-induced psoriasis-like skin inflammation. J Clin Invest 2006, 116:2094-2104.
31. Sallusto F. Origin and migratory properties of dendritic cells in the skin. Curr Opin Allergy Clin Immunol 2001, 1:441-448.
32. Romero E.L., Morilla M.J. Topical and mucosal liposomes for vaccine delivery. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2011, 3:356-375.
33. Cevc G., Vierl U. Nanotechnology and the transdermal route: a state of the art review and critical appraisal. J Control Release 2010, 141:277-299.
34. Sprott G.D. Structures of archaebacterial membrane lipids. J Bioenerg Biomembr 1992, 24:555-566.
35. De Rosa M., Tricone A., Nicolaus B., Gambacorta A. Archaeabacteria: lipids, Membranes Structures and Adaptations to Environmental Stresses. Life Under Extreme Conditions 1991, 61-78. Springer, New York. G. di Prisco (Ed.).
36. Gurnani K., Kennedy J., Sad S., Sprott G.D., Krishnan L. Phosphatidylserine receptor-mediated recognition of archaeosome adjuvant promotes endocytosis and MHC class I cross-presentation of the entrapped antigen by phagosome-to-cytosol transport and classical processing. J Immunol 2004, 173:566-578.
37. Krishnan L., Sad S., Patel G.B., Sprott G.D. Archaeosomes induce long-term CD81 cytotoxic T cell response to entrapped soluble protein by the exogenous cytosolic pathway, in the absence of CD41 T cell help1. J Immunol 2000, 165:5177-5185.
38. Hoffmann P.R., Kench J.A., Vondracek A., Kruk E., Daleke D.L., Jordan M., et al. Interaction between phosphatidylserine and the phosphatidylserine receptor inhibits immune responses in vivo. J Immunol 2005, 174:1393-1404.
39. Sprott G.D., Sad S., Fleming L.P., Dicaire C., Patel G.B., Krishnan L. Archaeosomes varying in lipid composition differ in receptor-mediated endocytosis and differentially adjuvant immune responses to entrapped antigen. Archaea 2003, 1:151-164.
40. Krishnan L., Sprott G.D. Archaeosome adjuvants: Immunological capabilities and mechanism(s) of action. Vaccine 2008, 26:2043-2055.
41. Eckburg P.B., Lepp P.W., Relman D.A. Archaea and their potential role in human disease. Infect Immun 2003, 71:591-596.
42. Pulendran B., Palucka K., Banchereau J. Sensing pathogens and tuning immune responses. Science 2001, 293:253-256.
43. Krishnan L., Gurnani K., Dicaire C.J., van Faassen H., Zafer A., Kirschning C.J., et al. Rapid clonal expansion and prolonged maintenance of memory CD8+ T cells of the effector (CD44highCD62Llow) and central (CD44highCD62Lhigh) phenotype by an archaeosome adjuvant independent of TLR2. J Immunol 2007, 178:2396-2406.
44. de la Salle H., Mariotti S., Angenieux C., Gilleron M., Garcia-Alles L.-F., Malm D., et al. Assistance of microbial glycolipid antigen processing by CD1e. Science 2005, 310:1321-1324.
45. McGreal E.P., Rosas M., Brown G.D., Zamze S., Wong S.Y.C., Gordon S., et al. The carbohydrate-recognition domain of Dectin-2 is a C-type lectin with specificity for high mannose. Glycobiology 2006, 16:422-430.
46. Sprott G.D., Dicaire C.J., Côtè J.-P., Whitfield D.M. Adjuvant potential of archaeal synthetic glycolipid mimetics critically depends on the glyco head group structure. Glycobiology 2008, 18:559-565.
47. Whitfield D.M., Eichler E.E., Sprott G.D. Synthesis of archaeal glycolipid adjuvants-what is the optimum number of sugars?. Carbohydr Res 2008, 343:2349-2360.
48. Kamekura M., Kates M. Structural diversity of membrane lipids in members of Halobacteriaceae. Biosci Biotechnol Biochem 1999, 63:969-972.